Zingo
Product Images NDC 61388-001

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Zingo (NDC 61388-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Powder Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Zingo 1)

An instructional illustration showing hands tearing open a sachet at the notch. This image likely demonstrates how to open the Zingo product packaging safely and effectively.*

FDA Label Image

Ndc 61388-001-48 Zingo ™ (lidocaine Hydrochloride Monohydrate) Powder Intradermal Injection System 0.5mg Rx Only. Manufactured By: Powder Pharmaceuticals, Inc. Hong Kong, China (Zingo 10)

Label for Zingo powder intradermal injection system containing 0.5 mg lidocaine hydrochloride monohydrate. The label indicates single-use, RX only, with storage instructions and manufacturer Powder Pharmaceuticals Inc. Hong Kong, China. Includes NDC 61388-001-48 and a barcode. The product brand name is prominent in purple text.*

FDA Label Image

Figure 1b (Zingo 2)

An instructional illustration shows a hand holding a device labeled with a 'Start Button' at the top and an 'Outlet' at the bottom, demonstrating proper grip for use.*

FDA Label Image

Figure 2 (Zingo 3)

An instructional illustration depicting the use of an injection device. The image shows a hand holding the device positioned against the skin on the forearm, demonstrating the step of administering a subcutaneous injection with the product Zingo by Powder Pharmaceuticals Inc.*

FDA Label Image

Figure 3 (Zingo 4)

An instructional illustration showing hands preparing a Zingo inhaler device. One hand presses the top of the inhaler while the other stabilizes it, demonstrating how to activate or use the device for administration.*

FDA Label Image

Figure 4 (Zingo 5)

An instructional illustration showing proper use of an injection pen. The hand holds the pen perpendicular to the arm, with text advising to 'Avoid gaps' between the pen and the skin surface during administration.*

FDA Label Image

Figure 5a (Zingo 6)

An instructional illustration showing how to use the Zingo product by pressing the outlet against the skin with a downward arrow indicating the direction of application. The hand is squeezing the device to deliver its contents.*

FDA Label Image

Figure 5b (Zingo 7)

Illustration showing the safety configuration and operation steps for a device labeled Zingo by Powder Pharmaceuticals Inc. It depicts three stages: A) button locked in the safe position, B) pressing down against skin raises the button to an unlocked position, C) button ready to be pressed inward with the thumb while still pressing down against the skin.*

FDA Label Image

Figure 6 (Zingo 8)

An instructional diagram depicting a hand holding an injector device, positioned over a forearm. The image includes arrows indicating to push the button inward on the device and to inject downward into the arm, illustrating the proper use technique of the injector.*

FDA Label Image

Figure 7 (Zingo Structural Formula)

Chemical structure of Zingo's active ingredient, depicting a compound with a benzene ring, an amide group, and an N,N-diethyl substitution, also showing association with HCl and H2O molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.